Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

More accurate criteria are required for the selection of patients with node-negative breast cancer for systemic adjuvant therapy. Expression of epidermal growth factor receptor (EGFr) has been shown previously to be inversely related to oestrogen receptor (ER) in patients with operable breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, S., Richard, J., Sainsbury, C., Halcrow, P., Kelly, P., Angus, B., Wright, C., Henry, J., Farndon, J. R., Harris, A. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971641/
https://www.ncbi.nlm.nih.gov/pubmed/1846551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971641/
https://www.ncbi.nlm.nih.gov/pubmed/1846551

Ejemplares similares